Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

SHA:600594 Revenue

Guizhou Yibai Pharmaceutical had revenue of 358.84M CNY in the quarter ending March 31, 2026, a decrease of -28.44%. This brings the company's revenue in the last twelve months to 1.72B, down -18.19% year-over-year. In the year 2025, Guizhou Yibai Pharmaceutical had annual revenue of 1.86B, down -14.31%.

• Revenue (ttm): 1.72B
• Revenue Growth: -18.19%
• P/S Ratio: 1.88
• Revenue / Employee: 326.99K
• Employees: 5,261
• Market Cap: 3.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.86B	-311.11M	-14.31%
Dec 31, 2024	2.17B	-646.53M	-22.92%
Dec 31, 2023	2.82B	85.30M	3.12%
Dec 31, 2022	2.74B	-611.44M	-18.27%
Dec 31, 2021	3.35B	-66.49M	-1.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error